Myeloma and severe cholestasis.

Area of Science:

• Medicine
• Hepatology
• Oncology

Background:

• Amyloidosis frequently complicates multiple myeloma.
• Liver involvement is common in systemic amyloidosis.
• Hepatic dysfunction in amyloidosis is typically mild.

Observation:

• A 44-year-old patient with multiple myeloma presented with rapidly worsening liver disease.
• The patient exhibited severe intrahepatic cholestasis.
• Autopsy revealed extensive amyloid deposition primarily in the liver.

Findings:

• This case represents an unusual and severe cholestatic manifestation of hepatic amyloidosis.
• The rapid progression of liver dysfunction suggests a poor prognosis.
• Widespread amyloidosis was confirmed at autopsy, predominantly affecting the liver.

Implications:

• Severe cholestatic hepatic amyloidosis in multiple myeloma patients carries a uniformly poor prognosis.
• Early recognition of this rare presentation is crucial for patient management.
• Further research into the mechanisms and potential treatments for cholestatic hepatic amyloidosis is warranted.